ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,298, issued on Aug. 5, was assigned to UCL BUSENESS LTD (London).
"T cell receptor" was invented by Hans Stauss (London), Sharyn Thomas (London), Ben Willcox (Birmingham, Great Britain) and Fiyaz Mohammed (Birmingham, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an engineered T cell receptor (TCR) comprising at least one of the following amino acid residues: L96 of the Alpha chain; R9 of the Beta chain; Y10 of the Beta chain; T24 of the Alpha chain; V19 of the Alpha chain; T20 of the Alpha chain; M50 of the Alpha chain; T5 of the Alpha chain; Q8 of the Alpha chain; S86 of the Alpha chain; F39 of the Alph...